July 17, 2026
In a new byline for Pharmaceutical Executive, Pleio CEO Michael Oleksiw pushes back on pharma’s rush to automate patient support. As patient adherence AI gets pitched as the answer to scale, Oleksiw points to a harder truth: patients aren’t falling off their medications because they lack information—they’re falling off because no one checks in before the gap becomes a missed dose. He points to a truck driver managing a new prescription on the road, whose gaps in care were caught by a proactive phone call. Oleksiw draws a parallel to customer service, where AI agents have been rolled back across nearly every industry, and argues healthcare can’t afford to learn that lesson the same costly way.
June 17, 2026
In a new byline for MedCity News, Pleio CEO Michael Oleksiw argues that healthcare’s rush to automate patient engagement is outpacing the trust patients actually have in AI-led care. Drawing a parallel to Waymo’s Senate testimony on remote human operators, Oleksiw makes the case that fear, isolation, and eroded trust — not logistics — are the real drivers of medication nonadherence, and that no amount of automation can substitute for sustained human connection. The piece outlines what healthcare leaders should demand from AI vendors before they automate away the touchpoints that actually keep patients engaged.
June 5, 2026
Asembia 2026 brought the specialty pharmacy world together and the conversations are still resonating. Pleio CEO Michael Oleksiw and Chief Experience Officer Abby Reynolds, PharmD sat down with the Pharmacy Podcast Network for their annual Asembia Rewind, alongside leaders from across the specialty ecosystem. Tune in to hear their perspective on the future of patient engagement and why human connection remains at the heart of what Pleio does.